(Q38432288)

English

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer

scientific article published on 12 April 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 September 2017

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer (English)

1 reference

Europe PubMed Central

3 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Armando Santoro

object named as

A Santoro

15

0 references

Roberto Labianca

object named as

R Labianca

4

0 references

Alfredo Falcone

object named as

A Falcone

5

0 references

author name string

E Bajetta

1

1 reference

Europe PubMed Central

3 September 2017

I Floriani

2

1 reference

Europe PubMed Central

3 September 2017

M Di Bartolomeo

3

1 reference

Europe PubMed Central

3 September 2017

F Di Costanzo

6

1 reference

Europe PubMed Central

3 September 2017

G Comella

7

1 reference

Europe PubMed Central

3 September 2017

D Amadori

8

1 reference

Europe PubMed Central

3 September 2017

C Pinto

9

1 reference

Europe PubMed Central

3 September 2017

C Carlomagno

10

1 reference

Europe PubMed Central

3 September 2017

D Nitti

11

1 reference

Europe PubMed Central

3 September 2017

B Daniele

12

1 reference

Europe PubMed Central

3 September 2017

E Mini

13

1 reference

Europe PubMed Central

3 September 2017

D Poli

14

1 reference

Europe PubMed Central

3 September 2017

S Mosconi

16

1 reference

Europe PubMed Central

3 September 2017

R Casaretti

17

1 reference

Europe PubMed Central

3 September 2017

C Boni

18

1 reference

Europe PubMed Central

3 September 2017

G Pinotti

19

1 reference

Europe PubMed Central

3 September 2017

P Bidoli

20

1 reference

Europe PubMed Central

3 September 2017

L Landi

21

1 reference

Europe PubMed Central

3 September 2017

G Rosati

22

1 reference

Europe PubMed Central

3 September 2017

A Ravaioli

23

1 reference

Europe PubMed Central

3 September 2017

M Cantore

24

1 reference

Europe PubMed Central

3 September 2017

F Di Fabio

25

1 reference

Europe PubMed Central

3 September 2017

E Aitini

26

1 reference

Europe PubMed Central

3 September 2017

A Marchet

27

1 reference

Europe PubMed Central

3 September 2017

ITACA-S (Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach Trial) Study Group

28

1 reference

Europe PubMed Central

3 September 2017

publication date

12 April 2014

1 reference

Europe PubMed Central

3 September 2017

Annals of Oncology

1 reference

Europe PubMed Central

3 September 2017

25

1 reference

Europe PubMed Central

3 September 2017

1373-1378

1 reference

Europe PubMed Central

3 September 2017

7

1 reference

Europe PubMed Central

3 September 2017

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

A phase II study of preoperative chemotherapy with S-1 plus cisplatin followed by D2/D3 gastrectomy for clinically serosa-positive gastric cancer (JACCRO GC-01 study).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

Identifiers

10.1093/ANNONC/MDU146

1 reference

Europe PubMed Central

3 September 2017

1 reference

Europe PubMed Central

3 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38432288&oldid=1759608474"